AVBP logo

ArriVent BioPharma (AVBP) Selling, General & Administrative Expenses

Annual SGA

$15.30 M
+$5.60 M+57.68%

December 31, 2024


Summary


Performance

AVBP SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPexpensesmetrics:

Quarterly SGA

$3.54 M
-$602.00 K-14.53%

December 31, 2024


Summary


Performance

AVBP Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPexpensesmetrics:

TTM SGA

-$768.58 M
-$80.49 M-11.70%

December 31, 2024


Summary


Performance

AVBP TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherAVBPexpensesmetrics:

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

AVBP Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+57.7%-9.6%-5939.4%
3 y3 years--9.6%-5939.4%
5 y5 years--9.6%-5939.4%

AVBP Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+136.4%-14.5%+111.0%-768.3%at low
5 y5-yearat high+136.4%-14.5%+111.0%-768.3%at low
alltimeall timeat high+136.4%-14.5%+111.0%-768.3%at low

ArriVent BioPharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$15.30 M(+57.7%)
$3.54 M(-14.5%)
$15.30 M(+2.9%)
Sep 2024
-
$4.14 M(+5.7%)
$14.87 M(+13.0%)
Jun 2024
-
$3.92 M(+5.9%)
$13.16 M(+14.8%)
Mar 2024
-
$3.70 M(+19.0%)
$11.47 M(+18.2%)
Dec 2023
$9.71 M
$3.11 M(+27.6%)
$9.71 M(+15.6%)
DateAnnualQuarterlyTTM
Sep 2023
-
$2.44 M(+9.4%)
$8.39 M(+9.9%)
Jun 2023
-
$2.23 M(+15.0%)
$7.64 M(+41.1%)
Mar 2023
-
$1.94 M(+7.9%)
$5.41 M(+55.7%)
Dec 2022
$6.47 M
-
-
Dec 2022
-
$1.79 M(+6.9%)
$3.47 M(+106.9%)
Sep 2022
-
$1.68 M
$1.68 M

FAQ

  • What is ArriVent BioPharma annual SGA?
  • What is the all time high annual SGA for ArriVent BioPharma?
  • What is ArriVent BioPharma annual SGA year-on-year change?
  • What is ArriVent BioPharma quarterly SGA?
  • What is the all time high quarterly SGA for ArriVent BioPharma?
  • What is ArriVent BioPharma quarterly SGA year-on-year change?
  • What is ArriVent BioPharma TTM SGA?
  • What is the all time high TTM SGA for ArriVent BioPharma?
  • What is ArriVent BioPharma TTM SGA year-on-year change?

What is ArriVent BioPharma annual SGA?

The current annual SGA of AVBP is $15.30 M

What is the all time high annual SGA for ArriVent BioPharma?

ArriVent BioPharma all-time high annual SGA is $15.30 M

What is ArriVent BioPharma annual SGA year-on-year change?

Over the past year, AVBP annual SGA has changed by +$5.60 M (+57.68%)

What is ArriVent BioPharma quarterly SGA?

The current quarterly SGA of AVBP is $3.54 M

What is the all time high quarterly SGA for ArriVent BioPharma?

ArriVent BioPharma all-time high quarterly SGA is $4.14 M

What is ArriVent BioPharma quarterly SGA year-on-year change?

Over the past year, AVBP quarterly SGA has changed by -$377.00 K (-9.62%)

What is ArriVent BioPharma TTM SGA?

The current TTM SGA of AVBP is -$768.58 M

What is the all time high TTM SGA for ArriVent BioPharma?

ArriVent BioPharma all-time high TTM SGA is -$88.51 M

What is ArriVent BioPharma TTM SGA year-on-year change?

Over the past year, AVBP TTM SGA has changed by -$781.74 M (-5939.36%)